Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0000899140-18-000457
Filing Date
2018-07-23
Accepted
2018-07-23 12:59:53
Documents
1
Effectiveness Date
2018-07-23
Items
Item 06b:
Item 3C: Investment Company Act Section 3(c)
Item 3C.7: Section 3(c)(7)

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 5996
  Complete submission text file 0000899140-18-000457.txt   7110
Mailing Address 70 E 55TH STREET, 14TH FLOOR NEW YORK NY 10022
Business Address 70 E 55TH STREET, 14TH FLOOR NEW YORK NY 10022 212-224-0633
22C Target Pharma Investors Rollover, LLC (Filer) CIK: 0001746768 (see all company filings)

EIN.: 830937410 | State of Incorp.: DE
Type: D | Act: 33 | File No.: 021-317493 | Film No.: 18964133